Pluristem Therapeutics, Inc. (NASDAQ:PSTI)

CAPS Rating: 1 out of 5

Results 1 - 9 of 9

Recs

0
Member Avatar zzlangerhans (99.78) Submitted: 3/12/2016 5:33:58 AM : Underperform Start Price: $1.53 PSTI Score: -13.42

Pluristem has shrugged off the 2016 bio doldrums behind what no doubt is some heavy promotional activity, since they haven't actually accomplished anything of late. Since I don't have a fax machine, my only clue to who is behind the latest move comes from the Yahoo-linked site Accesswire, which is a tool of shady stock promoter Ray Dirks. Pluristem has also been a favorite toy of the Axis of Evil, at the center of which sits M.E.Garza. There's no way for me to know if they're also involved in the current pump. The last potential player is Maxim, a bottom-of-the-barrel boiler room brokerage that maintains an eternal buy rating on Pluristem.

Stripping away the promotion, there's very little going on at Pluristem to justify the recent double in share price. The company is planning trials of their placental stem cell soup for limb ischemia, acute radiation sickness, and hematopoietic recovery after HSCT but there's very little in the way of clinical trials actually going on. Pluristem only has 44M in cash and a 130M market cap, making them extremely vulnerable to declining back below 1 as soon as the promoters have taken their profits and moved on. Of course, prior hype has driven Pluristem's share price almost as high as 4 just a year ago, so it might be judicious to wait a while longer before entering a short here.

Recs

0
Member Avatar clangmead (60.73) Submitted: 2/11/2016 9:39:35 AM : Outperform Start Price: $0.80 PSTI Score: +111.17

mpor1

Recs

0
Member Avatar SnarkyApple (54.73) Submitted: 9/13/2012 11:41:00 PM : Underperform Start Price: $3.90 PSTI Score: +94.58

Shenanigans.

Recs

0
Member Avatar shaito (< 20) Submitted: 8/20/2012 1:07:19 AM : Outperform Start Price: $3.98 PSTI Score: -100.35

the stock its in her lower price and other company with the same prodact without any life saver like psti the stoock need to be like 7-8 dollars

Recs

0
Member Avatar dolpho2 (< 20) Submitted: 8/17/2012 4:06:30 PM : Outperform Start Price: $3.98 PSTI Score: -100.35

Their technology seems to work. PLX-PAD is the only drug that heals the heart muscle instead of just prolonging life. Their drug for aplastic anaemia has been given to two people in a tel aviv hospital under Israel's compassion rule for terminal patients and both have survived. Looks like exciting work in their "snake oil". People seem to be scared of any new technology and will wait until they have a product on the market, missing the big run up (or down) during the development.

Recs

0
Member Avatar SuzaAdam (< 20) Submitted: 8/17/2012 3:35:08 PM : Outperform Start Price: $4.16 PSTI Score: -102.27

Superior technology

Recs

0
Member Avatar Ronsevet (< 20) Submitted: 3/29/2012 3:34:28 AM : Outperform Start Price: $2.21 PSTI Score: -66.76

A very well oriented stem company, with technological aspirations well in the realm of reality, extended their bioreactor capabilities just now,two phase two trials to be released in the near future with nice track record behind them.

Recs

0
Member Avatar dgoldmeier (33.04) Submitted: 3/4/2011 4:30:52 PM : Outperform Start Price: $2.33 PSTI Score: -78.48

needs time and money to develop, but if it is sucsessfull will become a billion + powerhouse.

Recs

0
Member Avatar NanoORBust (< 20) Submitted: 2/3/2011 5:41:51 PM : Outperform Start Price: $2.98 PSTI Score: -97.64

Seems to be following that pattern set by Mesoblast only with a much smaller market cap.

Results 1 - 9 of 9

Featured Broker Partners